rs9928278
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001009944.3(PKD1):c.8949-17A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 1,610,012 control chromosomes in the GnomAD database, including 29,785 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 6793 hom., cov: 33)
Exomes 𝑓: 0.16 ( 22992 hom. )
Consequence
PKD1
NM_001009944.3 intron
NM_001009944.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.41
Publications
10 publications found
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
- autosomal dominant polycystic kidney diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polycystic kidney disease 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Caroli diseaseInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 16-2102650-T-C is Benign according to our data. Variant chr16-2102650-T-C is described in ClinVar as Benign. ClinVar VariationId is 257034.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.493 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PKD1 | NM_001009944.3 | c.8949-17A>G | intron_variant | Intron 24 of 45 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.253 AC: 38407AN: 152008Hom.: 6771 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
38407
AN:
152008
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.160 AC: 39456AN: 246746 AF XY: 0.154 show subpopulations
GnomAD2 exomes
AF:
AC:
39456
AN:
246746
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.164 AC: 239165AN: 1457886Hom.: 22992 Cov.: 35 AF XY: 0.161 AC XY: 116601AN XY: 725288 show subpopulations
GnomAD4 exome
AF:
AC:
239165
AN:
1457886
Hom.:
Cov.:
35
AF XY:
AC XY:
116601
AN XY:
725288
show subpopulations
African (AFR)
AF:
AC:
17129
AN:
33368
American (AMR)
AF:
AC:
5419
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
AC:
6157
AN:
26116
East Asian (EAS)
AF:
AC:
16
AN:
39698
South Asian (SAS)
AF:
AC:
6480
AN:
86168
European-Finnish (FIN)
AF:
AC:
9448
AN:
52024
Middle Eastern (MID)
AF:
AC:
1002
AN:
4344
European-Non Finnish (NFE)
AF:
AC:
182880
AN:
1111296
Other (OTH)
AF:
AC:
10634
AN:
60168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
11910
23819
35729
47638
59548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6586
13172
19758
26344
32930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.253 AC: 38474AN: 152126Hom.: 6793 Cov.: 33 AF XY: 0.247 AC XY: 18391AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
38474
AN:
152126
Hom.:
Cov.:
33
AF XY:
AC XY:
18391
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
20705
AN:
41484
American (AMR)
AF:
AC:
2840
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
804
AN:
3468
East Asian (EAS)
AF:
AC:
9
AN:
5172
South Asian (SAS)
AF:
AC:
342
AN:
4828
European-Finnish (FIN)
AF:
AC:
2017
AN:
10590
Middle Eastern (MID)
AF:
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11089
AN:
67970
Other (OTH)
AF:
AC:
505
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1374
2748
4123
5497
6871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
352
704
1056
1408
1760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
255
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 01, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 25, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Polycystic kidney disease, adult type Benign:1
Jul 07, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal dominant polycystic kidney disease Benign:1
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.